AGO2 in T-prolymphocytic leukemia (T-PLL)
A new editorial paper titled "AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function" has been published in Oncotarget.
Aug 7, 2023
0
2
A new editorial paper titled "AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function" has been published in Oncotarget.
Aug 7, 2023
0
2
Peter Maloca, group leader at IOB for Ophthalmic Imaging, and Konstantin Gugleta, senior attending physician at the University Hospital Eye Clinic Basel and Henner Hanssen, Head of Preventive Sports Medicine & Systems Physiology, ...
Jun 2, 2020
0
0
Humans encounter innumerable pathogenic bacteria, viruses and other microbes in their day-to-day activities. While infections from some pathogens can be easily cleared by the innate immune system, others can evade this first ...
May 11, 2023
0
2
New research by the University Hospital Bonn (UKB) in cooperation with the University of Bonn has shown for the first time that certain early changes in patients with age-related macular degeneration (AMD) can lead to a measurable ...
Jul 10, 2024
0
15
Researchers at the Brain and Spine Institute at John Theurer Cancer Center at HackensackUMC, one of the nation's 50 best hospitals for cancer, are studying a possible alternative to side effect-ridden opioid-based medications ...
Jun 26, 2013
0
1
A new microporous scaffold functions as a minimally-invasive surveillance method to identify rejection prior to graft injury in a mouse model, according to a study published in Science Advances.
May 17, 2024
0
3
The bloodborne chemical signal sphingosine-1-phosphate (S1P) is released by blood cells to regulate immune and vascular functions. How S1P is released to the circulation was unknown for a long time, until now. On October ...
Oct 23, 2017
0
1
The innate immune system detects invasive pathogens and activates defense mechanisms to eliminate them. Pathogens, however, employ a variety of tricks to block this process. A new study shows how the measles virus thwarts ...
Jan 22, 2013
0
0
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with ...
Feb 7, 2013
0
0
(HealthDay)—Although physicians typically struggle with change, relying on habits created in their practice, learning to change is important in order to improve practices and better deal with the changes sweeping through ...
Aug 1, 2018
0
0